Greden JF. The burden of recurrent depression: causes, consequences, and future prospects. The Journal of Clinical Psychiatry 2001;62 Suppl 22:5-9.
Lewis L, Hoofnagle L. Treatment-resistant depression: the patient perspective. Biological Psychiatry 2003;53(8):635-9.
Pirnia T, Joshi SH, Leaver AM, Vasavada M, Njau S, Woods RP, et al. Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex 2016;6(6):e832.
Nemeroff CB. Prevalence and management of treatment-resistant depression. The Journal of Clinical Psychiatry 2007;68 Suppl 8:17-25.
Wasserman D. Depression: The Facts: Oxford University Press; 2006.
Baldwin CM, Birtwistle J. An Atlas of Depression: Taylor & Francis; 2002.
Husain SS, Kevan IM, Linnell R, Scott AI. What do psychiatrists mean by medication resistance as an indication for electroconvulsive therapy? The journal of ECT 2005;21(4):211-3.
Braga RJ, Petrides G. [Somatic therapies for treatment-resistant psychiatric disorders]. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999) 2007;29 Suppl 2:S77-84.
Park M, Niciu MJ, Zarate CA, Jr. Novel Glutamatergic Treatments for Severe Mood Disorders. Current Behavioral Neuroscience Reports 2015;2(4):198-208.
Zorumski CF, Nagele P, Mennerick S, Conway CR. Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy. Frontiers in Psychiatry 2015;6:172.
Luo J, Min S, Wei K, Cao J, Wang B, Li P, et al. Propofol prevents electroconvulsive-shock-induced memory impairment through regulation of hippocampal synaptic plasticity in a rat model of depression. Neuropsychiatric Disease and Treatment 2014;10:1847-59.
Luo J, Min S, Wei K, Zhang J, Liu Y. Propofol interacts with stimulus intensities of electroconvulsive shock to regulate behavior and hippocampal BDNF in a rat model of depression. Psychiatry Research 2012;198(2):300-6.
Abdul Shukkoor MS, Baharuldin MT. Antidepressant-Like effect of lipid extract of channa striatus in chronic unpredictable mild stress model of depression in rats 2016:2986090.
Spiacci A, Jr., Kanamaru F, Guimaraes FS, Oliveira RM. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacology, Biochemistry, and Behavior 2008;88(3):247-55.
Sulakhiya K, Patel VK, Saxena R, Dashore J, Srivastava AK, Rathore M. Effect of Beta vulgaris Linn. Leaves extract on anxiety- and depressive-like behavior and oxidative stress in mice after acute restraint stress. Pharmacognosy Research 2016;8(1):1-7.
Doremus-Fitzwater TL, Varlinskaya EI, Spear LP. Social and non-social anxiety in adolescent and adult rats after repeated restraint. Physiology & Behavior 2009;97(3-4):484-94.
Hodge CW, Raber J, McMahon T, Walter H, Sanchez-Perez AM, Olive MF, et al. Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. The Journal of Clinical Investigation 2002;110(7):1003-10.
McCarthy MM, Nielsen DA, Goldman D. Antisense oligonucleotide inhibition of tryptophan hydroxylase activity in mouse brain. Regulatory Peptides 1995;59(2):163-70.
Willner P, Mitchell PJ. The validity of animal models of predisposition to depression. Behavioural Pharmacology 2002;13(3):169-88.
Mohamed BM, Aboul-Fotouh S, Ibrahim EA, Shehata H, Mansour AA, Yassin NA, et al. Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-alpha and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats. Neuropsychiatric Disease and Treatment 2013;9:697-708.
Yang Y, Hu Z, Du X, Davies H, Huo X, Fang M. miR-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats. Frontiers in Neuroscience 2017;11:428.
Luo KR, Hong CJ, Liou YJ, Hou SJ, Huang YH, Tsai SJ. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2010;34(8):1433-9.
Qi X, Lin W, Li J, Li H, Wang W, Wang D, et al. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress Neurobiology of Disease 2008;31(2):278-85.
Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The forced swim test as a model of depressive-like behavior. Journal of Visualized Experiments 2015(97).
Nitsche MA, Boggio PS, Fregni F, Pascual-Leone A. Treatment of depression with transcranial direct current stimulation (tDCS): a review. Experimental Neurology 2009;219(1):14-9.
Duman RS. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues in Clinical Neuroscience 2014;16(1):11-27.